Literature DB >> 2712060

Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome.

J W Engstrom1, D H Lowenstein, D E Bredesen.   

Abstract

PURPOSE: Little information is available concerning the clinical importance of cerebral infarction in patients with acquired immunodeficiency syndrome (AIDS). The purpose of this retrospective study was two-fold: (1) to determine the frequency and clinical characteristics of cerebral infarction and transient neurologic deficits (TNDs) among patients with AIDS; and (2) to identify specific patient subgroups at risk for such complications and whether there were underlying associated diseases requiring specific therapy. PATIENTS AND METHODS: Neurology inpatient and consult service records, neuropathology reports, and the University of California, San Francisco, AIDS computerized registry were used in identifying study cases. Information on demographic background, associated clinical diagnoses, presenting neurologic symptoms and signs, laboratory results, pathologic findings, and clinical follow-up was obtained from each patient's medical record.
RESULTS: Twenty-five patients with AIDS (mean age, 38) having clinical or pathologic findings suggestive of focal cerebral ischemia or infarction were identified. Ten patients had non-hemorrhagic cerebral infarctions, 13 had acute TNDs, and two had both. Cerebral infarction was associated with central nervous system (CNS) infections (cryptococcus, four; tuberculosis, one; zoster vasculitis, one) and cardiogenic embolism (one). TNDs were associated with toxoplasmosis (four), cerebral infarction (two), cryptococcal meningitis (one), vasculitis (one), and CNS Kaposi's sarcoma (one). A presumptive cause was absent in five cases of cerebral infarction and eight of TND. All five patients with pathologically proven macroscopic cerebral infarcts were diagnosed clinically before death.
CONCLUSIONS: We conclude the following: (1) AIDS patients, especially given their young age, appear to be increased risk for cerebral infarction and TND. (2) Cerebral infarction and TND may be the initial presentation of AIDS. (3) TND and cerebral infarction often signify treatable CNS infection among AIDS patients. (4) The causes of AIDS-related cerebral infarction and TND are unknown in many cases.

Entities:  

Mesh:

Year:  1989        PMID: 2712060     DOI: 10.1016/0002-9343(89)90379-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

1.  Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein.

Authors:  M Chung; K Kizhatil; L M Albritton; G N Gaulton
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  TIA--treacherously inaccurate acronym.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2002

3.  Stroke in an HIV-infected patient.

Authors:  A Atalaia; J Ferro; F Antunes
Journal:  J Neurol       Date:  1992-07       Impact factor: 4.849

4.  Role of metabolic syndrome components in human immunodeficiency virus-associated stroke.

Authors:  Beau M Ances; Archana Bhatt; Florin Vaida; Debralee Rosario; Terry Alexander; Jennifer Marquie-Beck; Ronald J Ellis; Scott Letendre; Igor Grant; J Allen McCutchan
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

Review 5.  The pathogenesis of the neurological complications of HIV-1 infection.

Authors:  B J Brew
Journal:  Genitourin Med       Date:  1993-10

Review 6.  Neurologic and psychiatric manifestations of HIV disease.

Authors:  H Hollander
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

7.  Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus.

Authors:  B H Park; E Lavi; K J Blank; G N Gaulton
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  Endothelin-1 immunoreactivity in plasma is elevated in HIV-1 infected patients with retinal microangiopathic syndrome.

Authors:  B Rolinski; S A Geier; I Sadri; V Klauss; J R Bogner; H Ehrenreich; F D Goebel
Journal:  Clin Investig       Date:  1994-03

9.  HIV stroke risk: evidence and implications.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah L Commins; William Yong; Margrit Carlson
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

10.  Nonopportunistic neurologic manifestations of the human immunodeficiency virus: an Indian study.

Authors:  Alaka K Deshpande; Mrinal M Patnaik
Journal:  J Int AIDS Soc       Date:  2005-10-04       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.